1-3 of 3
Torben Elm
Close
Sort by
Journal Articles

A novel B-domain O -glycoPEGylated FVIII (N8-GP) demonstrates full efficacy and prolonged effect in hemophilic mice models

Henning R. Stennicke, Marianne Kjalke, Ditte M. Karpf, Kristoffer W. Balling, Peter B. Johansen, Torben Elm, Kristine Øvlisen, Flemming Möller, Heidi L. Holmberg, Charlotte N. Gudme, Egon Persson, Ida Hilden, Hermann Pelzer, Henrik Rahbek-Nielsen, Christina Jespersgaard, Are Bogsnes, Anette A. Pedersen, Anne K. Kristensen, Bernd Peschke, Wendy Kappers, Frederik Rode, Lars Thim, Mikael Tranholm, Mirella Ezban, Eva H. N. Olsen, Søren E. Bjørn
Journal: Blood
Blood (2013) 121 (11): 2108–2116.
https://doi.org/10.1182/blood-2012-01-407494
Published: 2013
Includes: Supplemental data
Journal Articles

Prolonged half-life and preserved enzymatic properties of factor IX selectively PEGylated on native N-glycans in the activation peptide

Henrik Østergaard, Jais R. Bjelke, Lene Hansen, Lars Christian Petersen, Anette A. Pedersen, Torben Elm, Flemming Møller, Mette B. Hermit, Pernille K. Holm, Thomas N. Krogh, Jørn M. Petersen, Mirella Ezban, Brit B. Sørensen, Mette D. Andersen, Henrik Agersø, Haleh Ahmadian, Kristoffer W. Balling, Marie Louise S. Christiansen, Karin Knobe, Timothy C. Nichols, Søren E. Bjørn, Mikael Tranholm
Journal: Blood
Blood (2011) 118 (8): 2333–2341.
https://doi.org/10.1182/blood-2011-02-336172
Published: 2011
Includes: Supplemental data
Journal Articles

Reaction of Factor VIIa (VIIa) with Plasma Inhibitors Ex Vivo and In Vivo .

Lars C. Petersen, Carsten L. Christoffersen, Thomas N. Krogh, Torben Elm
Journal: Blood
Blood (2006) 108 (11): 1750.
https://doi.org/10.1182/blood.V108.11.1750.1750
Published: 2006